Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?

Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Zacks Investment Research • 5 hours ago

Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?

Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • 4 hours ago

Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?

Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 23, 2026

Labcorp Prepares to Report Q2 Earnings: What's in the Cards?

LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.

Zacks Investment Research • Jul 22, 2026

Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?

Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 21, 2026

Labcorp Holdings: The Story Has Not Changed Materially

Labcorp remains a buy consideration, leveraging a successful rollup strategy in a fragmented laboratory testing industry for steady, predictable growth. Automation is driving cost reductions in LH's operations. That cost reduction helps offset healthcare pricing pressures. With a larger scale, LH now targets single-digit growth and a total return around 10%, prioritizing predictability over rapid expansion.

Seeking Alpha • Jul 16, 2026

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Jul 13, 2026

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C., July 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

PRNewsWire • Jul 9, 2026

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jul 7, 2026

LH or CRL: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jul 1, 2026